XML 92 R75.htm IDEA: XBRL DOCUMENT v3.20.4
Equity-Based Compensation and Equity - Additional Information (Detail) - USD ($)
 12 Months Ended
Jan. 15, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2014
Dec. 31, 2017
Share Based Compensation Arrangement By Share Based Payment Award Remaining Award Vesting Value Year One   $ 5,700,000        
Share Based Compensation Arrangement By Share Based Payment Award Remaining Award Vesting Value Year Two   $ 400,000        
Common stock, shares authorized   3,290,000,000 3,290,000,000      
Common stock, par value (in Dollars per share)   $ 0.0001 $ 0.0001      
Common stock, shares issued   318,425,182 203,750,000      
Common stock, shares outstanding   318,425,182 203,750,000      
Preferred stock, shares authorized   10,000,000 10,000,000      
Preferred stock, par value (in Dollars per share)   $ 0 $ 0      
Preferred stock, shares issued   0 0      
Preferred stock, shares outstanding   0 0      
Exercise price per share   $ 0.01        
Description of common stock   if, and only if, the last reported closing price of the common stock equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganizations, reclassifications, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.        
Private Placement [Member]            
Issuance of common stock to sponsor, Shares   7,333,333        
Number of days restriction upon warrants or rights exercisable   30 days        
Public Warrants [Member]            
Class of warrant, outstanding   11,250,000        
Exercise price per share   $ 11.50        
Number of days warrants or rights exercisable   30 days        
Number of years warrants or rights will expire after the completion of the merger   5 years        
Common Class A [Member]            
Common stock, shares authorized   3,920,000,000        
Common stock, par value (in Dollars per share)   $ 0.0001        
Common stock, shares issued   318,425,182        
Common stock, shares outstanding     318,425,182      
Exercise price per share   $ 11.50        
Number of days restriction upon warrants or rights exercisable after redemption notice issued   30 days        
Proceeds from warrant exercises   $ 0        
Description of warrant redemption   at a price of $0.10 per warrant, provided that the warrant holders will be able to exercise their warrants prior to redemption and receive that number of shares of Class A common stock to be determined by reference to a table included in the warrant agreement, based on the redemption date and the fair market value of the Class A common stock;        
Description of common stock   if, and only if, the last reported closing price of the common stock equals or exceeds $10.00 per share (as adjusted for share splits, share dividends, reorganizations, reclassifications, recapitalizations and the like) on the trading day prior to the date on which the Company sends notice of redemption to the warrant holders;        
Selling, General and Administrative Expenses [Member]            
Compensation expense   $ 13,800,000 $ 1,300,000      
Share Based Compensation Gain (Loss)       $ 8,200,000    
Share-based Payment Arrangement, Expense   $ 13,800,000 $ 1,300,000      
Common Series D Units [Member]            
Equity -based compensation , units issued   0 0 0 30,000  
Vesting period   5 years        
Equity -based compensation ,grant date fair value   $ 300.00 $ 300.00 $ 300.00    
Equity -based compensation , fair value end of measurement period   $ 644 $ 184 $ 165    
Equity -based compensation ,numbers of units outstanding   30,000        
Common Series C Units [Member]            
Equity -based compensation , units issued   2,900 21,953 10,830    
Description of vesting rights   As the result of an amendment and restatement of the Limited Partnership Agreement, on March 15, 2018, 75% of all Common Series C Units awards are subject to vesting over four fiscal years from their respective issuance date. The remaining 25% of the units vest if and when Topco’s private equity sponsors as of the date of the 2014 Topco Acquisition realize a pre-tax internal rate of return of 20% compounded annually with respect to the Common Series A Units of Topco held by such sponsors.        
Compensation expense   $ 62,700,000 $ 0 $ 0    
Equity -based compensation ,grant date fair value   $ 201.25 $ 37.90 $ 167.40    
Equity -based compensation ,numbers of units outstanding   172,026 174,190 156,975   150,906
Share-based Payment Arrangement, Expense   $ 62,700,000 $ 0 $ 0    
Common Series C Units [Member] | Share-based Payment Arrangement, Tranche One [Member]            
Vesting percentage   75.00%        
Vesting period   4 years        
Common Series C Units [Member] | Share-based Payment Arrangement, Tranche Two [Member] | 2014 Topco Acquisition [Member]            
Vesting percentage   25.00%        
Common Series C Units [Member] | Share-based Payment Arrangement, Tranche Three [Member] | Daymon Acquisition [Member]            
Vesting period   4 years        
Common Series C2 Units [Member]            
Equity -based compensation , units issued   2,500 1,425 34,275    
Compensation expense   $ 13,300,000 $ 0 $ 0    
Equity -based compensation ,grant date fair value   $ 223.00 $ 284.00 $ 652.99    
Equity -based compensation ,numbers of units outstanding   32,275 33,400 33,525    
Share-based Payment Arrangement, Expense   $ 13,300,000 $ 0 $ 0    
Common Series C2 Units [Member] | 2014 Topco Acquisition [Member]            
Equity-based compensation ,units authorized   35,000        
Performance Shares [Member] | Common Class A [Member] | Topco [Member] | Subsequent Event [Member]            
Issuance of common stock to sponsor, Shares 5,000,000